Ophthalmologists are among Medicare's highest paid specialists-a finding already drawing scrutiny from policymakers and watchdogs worried about waste and overuse.
Ophthalmologists are among Medicare's highest paid specialists—a finding already drawing scrutiny from policymakers and watchdogs worried about waste and overuse. But doctors' advocates say the data shouldn't be interpreted as eye doctors getting rich off the government's senior citizen healthcare program.
A closer inspection of the data reveals that many of the highest-paying codes for eye doctors relate to the use of Lucentis, a branded injectible drug for macular degeneration that costs $2,000 a dose.
Medicare rules let doctors mark up the price of drugs delivered in their offices by 6% over the manufacturer's average sale price. The additional fee was designed to help physicians defray the cost of running their facilities.
Read the full story here: http://bit.ly/1eoqoy9
Source: Modern Healthcare
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen